Publicaciones en colaboración con investigadores/as de University of Utah (3)

2020

  1. Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection

    Biochemical Pharmacology, Vol. 182

2019

  1. Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia

    Journal of Cancer Research and Clinical Oncology, Vol. 145, Núm. 6, pp. 1589-1599

2018

  1. Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial

    Journal of Clinical Oncology, Vol. 36, Núm. 3, pp. 231-237